Drug Res (Stuttg)
DOI: 10.1055/a-2695-0339
Original Article

Characterization and Therapeutic Assessment of Phytomediated Silver Nanoparticles Produced from the Stem Bark of Bombax ceiba

Authors

  • Narendhar Dharavath

    1   Department of Chemical Engineering, National Institute of Technology, Warangal, India (Ringgold ID: RIN28673)
  • Mahendar Porika

    2   Department of Biotechnology, Kakatiya University, Warangal, India (Ringgold ID: RIN28672)
  • Radhika Tippani

    2   Department of Biotechnology, Kakatiya University, Warangal, India (Ringgold ID: RIN28672)
  • Anand Kishore Kola

    1   Department of Chemical Engineering, National Institute of Technology, Warangal, India (Ringgold ID: RIN28673)
  • Tomy Murigingayil Joseph

    3   Faculty of Chemistry, Department of Polymer Technology, Gdańsk University of Technology, Gdańsk, Poland (Ringgold ID: RIN49557)
  • Maxim Shevtsov

    4   Institute of Cytology of the Russian Academy of Sciences (RAS), Saint Petersburg, Russia (Ringgold ID: RIN68602)
  • Shirish H Sonawane

    1   Department of Chemical Engineering, National Institute of Technology, Warangal, India (Ringgold ID: RIN28673)
Preview

Abstract

The study aims to develop an environmentally friendly method of producing silver nanoparticles using an extract from Bombax ceiba stem bark (Bc-AgNPs) and to investigate their potential medical applications, such as preventing blood cell damage, combating oxidation, and lowering inflammation. The synthesized Bc-AgNPs were characterized using UV–visible spectroscopy, X-ray diffraction (XRD), Fourier transform infrared spectroscopy, and transmission electron microscopy (TEM). The zeta potential examination revealed a highly stable colloidal solution of Bc-AgNPs with a surface charge of−14 mV. The synthesized Bc-AgNPs had a face-centred cubic structure with a crystalline size of 26 nm and an average grain size of 59.8 nm, as seen in the TEM images. Bc-AgNPs showed no hemolysis at varied concentrations, but B. ceiba stem bark extract at 100 µg/mL caused 16.8±1.9% hemolysis, and Triton X-100 (0.1%; positive control) caused 99.1±0.4% hemolysis. B. ceiba’s aqueous extract contained flavonoid and phenolic components, which enhanced Bc-AgNPs’ antioxidant capacity. The relative IC50 values were 28.03±0.98 µg/mL and 33.7±0.38 µg/mL. When compared to a reference medication, Bc-AgNPs demonstrated a moderate antiinflammatory effect, with IC50 values of 42.26±0.74 µg/mL for BSA and 50.93±1.07 µg/mL for egg albumin assay. According to the study, bio/hemocompatible Bc-AgNPs may be a viable treatment choice for antiinflammatory and antioxidant treatments.

Supplementary Material



Publication History

Received: 24 June 2025

Accepted after revision: 04 August 2025

Article published online:
24 September 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany